Head and Neck Cancer / Free-Flap Reconstruction | Intensive monitoring and early recovery

A free flap is completely disconnected from its original blood supply and reconnected microsurgically in the head and neck, so postoperative monitoring aims to detect arterial or venous compromise early. Slow capillary refill with a pale flap suggests arterial insufficiency, while very swift refill with a bluish hue suggests impaired venous outflow. Bleeding colour and duration can add clues, but no single monitoring method has become the universally accepted standard. Depending on the defect, surgeons can make free flaps either thin and pliable, or bulky and padded. Recipient vessels should be outside the zone of injury, yet accessible and of adequate calibre.

Free-flap reconstruction rebuilds head and neck defects after cancer removal by reconnecting tiny blood vessels. A threatened flap means blood flow may be compromised, often from anastomotic problems, kinking, compression, hematoma or thrombosis. Monitoring skin colour, capillary return, temperature and Doppler flow helps detect compromise early. Early detection matters because salvage improves with shorter delay. Reported rates differ: re-operation in 2% to 9% of free tissue transfers, re-exploration for compromised circulation in 5% to 25%, and one series re-explored 10.63% of 207 cases, half with flap compromise. These figures come from different populations and study types, so they are not one universal probability.

The operation removes cancer and rebuilds the defect with living tissue whose blood supply is reconnected microsurgically. Swelling can narrow the airway, so most patients have a tracheostomy and frequent suctioning; humidified oxygen is given once ventilator support is reduced. Head elevation and avoiding pressure on the flap help protect blood flow. Sedation overnight may reduce agitation and vomiting, though it can require more intravenous fluids and may strain limited heart or lung reserve. Tracheostomy ties are avoided because pressure on the flap pedicle can threaten blood flow; the tube is sutured instead. Airway care stays meticulous while swelling settles.

A tracheostomy cuff that is inflated blocks airflow through the larynx, so speech may need cuff deflation or a speaking valve to redirect air during expiration. One described protocol downsizes the tube around the fifth postoperative day and decannulates around the sixth or seventh day after capping trials. In a specific hemilaryngeal reconstruction case, speech was possible during finger occlusion of the temporary tracheostomy, with hand-free speech after tracheostoma closure about six weeks after the second stage. These are not universal timelines for all free-flap reconstructions. Long-term speech also depends on cancer size and location, reconstruction type, tongue movement and motivation.

The team first considers your preoperative swallowing and aspiration risk. After surgery, the reconstructive surgeon decides when a swallow evaluation is permissible and when it is safe to test the suture line. If no flap is involved, evaluation may occur in the first few days; with a free flap, oral trials usually wait about five days, or fourteen days after prior radiation. Swallowing may be affected by swelling, reduced lip closure, slowed oral transit, residue, or reduced hyolaryngeal elevation. The speech-language pathologist assesses aspiration risk, safe diet tolerance, and may adjust textures, postures, or maneuvers. Nutrition may be oral, nasal tube, or PEG, decided jointly by surgeons.

Free flaps rebuild defects after tumour removal, but saliva can leak where flap meets native tissue. Intraoral flap fistulas occur in approximately 10% of cases, while radial forearm esophageal reconstruction carries about 15% to 20% risk. Previous radiotherapy increases risk. Meticulous suturing may reduce risk, but radiation still raises it. Conservative local management helps about 60% to 65% of cases; others need surgical revision. Free-flap reconstruction after salvage laryngectomy is associated with lower fistula risk than primary closure. A fistula may be recognised by saliva draining from the wound or the skin. Rates are not directly comparable across different operations.

The operation removes cancer and rebuilds the defect with living tissue whose blood supply is reconnected microsurgically. Because the mouth and throat lining must heal, you are usually kept nil by mouth at first; nutrition is given through a nasogastric tube once you are awake and reoperation is less likely. Oral hygiene may include irrigation, mechanical cleansing, chlorhexidine rinse every four hours, and humidified air to reduce dryness and crusting. Oral feeding is delayed, often seven to ten days, and swallowing may be checked before eating. Infection or deep-space collection can threaten the flap, so neck drainage and wound care matter.

Free-flap reconstruction moves living tissue with its blood supply from a donor site to repair a head and neck defect. Donor-site care varies by tissue harvested. After fibular harvest, keep the donor limb elevated when not walking to help skin graft healing. After bone or osteocutaneous harvest, shoulder motion is not immobilized; range-of-motion exercises begin within several days when the wound is intact and healing well, and full shoulder function is normally regained in about one month. After skin flap harvest, there are no special donor-area recommendations, and the donor incision usually needs three to four weeks for complete healing. There is no routine donor-site rehabilitation program, except physical therapy for uncooperative patients to avoid joint stiffness.

One reported inpatient protocol used scheduled acetaminophen 650 mg, celecoxib 200 mg and gabapentin 300 mg by mouth, with intravenous ketorolac 15 mg for breakthrough pain, morphine or oxycodone as needed, opioid PCA for opioid-tolerant patients, and aspirin 81 mg routinely. Epidural analgesia may provide good pain relief and vasodilation, but blood pressure must be maintained to avoid reduced flap blood flow. Excess intraoperative fluid has been associated with more complications in some studies. ERAS pathways also integrate pain control with airway, nutrition, flap monitoring and early mobilization. Pain is carefully reassessed regularly at both operative sites, and breakthrough pain may require additional opioids; regional techniques require careful blood-pressure monitoring.

Free flaps are living tissue moved with their blood vessels; failure can be partial or total. Surgeons consider whether critical structures are exposed, whether infection is controlled, and whether the patient can be reoptimized before further surgery. In one series, a failed head and neck free flap was usually replaced by another similar free flap, with a 94.1% success rate for the second free flap; regional flaps after failure had a higher subsequent complication rate in that series. Risk of failure may increase with repeated reconstructions. This is not a guarantee for any individual. Management depends on wound condition, exposed structures and overall health.